Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer

The Changes in MGMT Promoter Methylation Status in Initial and Recurrent Glioblastomas

(2014) Chul-Kee Park et al.   Translational Oncology

Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients

(2014) Dmitry A. Ovchinnikov et al.   Translational Oncology

Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen

(2012) Jana Jeschke et al.   Epigenetics

Detection of Promoter Hypermethylation in Salivary Rinses as a Biomarker for Head and Neck Squamous Cell Carcinoma Surveillance

(2011) A. L. Carvalho et al.   CLINICAL CANCER RESEARCH

Cancer epigenetics reaches mainstream oncology

(2011) Manuel Rodríguez-Paredes et al.   NATURE MEDICINE

Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma

(2010) Takeharu Kanazawa et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

G protein-coupled receptors: novel targets for drug discovery in cancer

(2010) Rosamaria Lappano et al.   NATURE REVIEWS DRUG DISCOVERY

Galanin Receptor Subtype 2 Suppresses Cell Proliferation and Induces Apoptosis in p53 Mutant Head and Neck Cancer Cells

(2009) T. Kanazawa et al.   CLINICAL CANCER RESEARCH

The combination of neurokinin-1 and galanin receptor antagonists ameliorates caerulein-induced acute pancreatitis in mice

(2009) Savio G. Barreto et al.   PEPTIDES

Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer

(2008) Stefan David et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer

(2008) K. Misawa et al.   CLINICAL CANCER RESEARCH

Expression of the tachykinin receptor mRNAs in healthy human colon

(2008) Nadia Jaafari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

DCC promoter hypermethylation in esophageal squamous cell carcinoma

(2008) Hannah Lui Park et al.   INTERNATIONAL JOURNAL OF CANCER

Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors

(2008) Zhe Jin et al.   INTERNATIONAL JOURNAL OF CANCER

EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer

(2008) Bhavna Kumar et al.   JOURNAL OF CLINICAL ONCOLOGY

Epigenetics in Cancer

(2008) Manel Esteller   NEW ENGLAND JOURNAL OF MEDICINE